世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

接着バリア市場：製品別（再生セルロース、ヒアルロン酸、PEG）、タイプ別（フィルム、ゲル、液体）、手技別（腹部、心臓血管、婦人科、神経）、エンドユーザー別（病院、クリニック、ASC）、地域別 - 2028年までの世界予測


Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (Film, Gel, Liquid), Procedure (Abdominal, Cardiovascular, Gynae, Neurology), End User (Hospitals, Clinics & ASC), Region - Global Forecast to 2028

癒着防止バリア市場は、2023年に推定7億米ドルと評価され、予測期間中の年平均成長率は7.4%で、2028年には9億米ドルに達すると予測されている。この市場の発展を促進する主な要因は、手術件数やスポーツ関連傷害... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年7月18日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		231 257 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

癒着防止バリア市場は、2023年に推定7億米ドルと評価され、予測期間中の年平均成長率は7.4%で、2028年には9億米ドルに達すると予測されている。この市場の発展を促進する主な要因は、手術件数やスポーツ関連傷害の増加、高齢者人口の増加、癒着形成や癒着に関連する疾患に対する意識の高まりである。

"接着バリア市場において、予測期間中、製品タイプ別では合成接着バリア市場が最も高い成長を遂げると予測される。"
製品に基づき、接着バリア市場はさらに合成接着バリアと天然接着バリアに区分される。合成接着バリアはさらに、ヒアルロン酸、再生セルロース、ポリエチレングリコール、その他の合成接着バリアに分類される。ヒアルロン酸ベースの接着バリアセグメントは、生体適合性と生体吸収性という特性により、合成接着バリア市場で最大のシェアを占めている。

"一般/腹部外科手術は接着バリア市場の最大の用途分野である"
2022年、用途別では、一般/腹部外科が接着バリア市場で最大のシェアを占めた。このセグメントの大きなシェアは、一般外科／腹部外科における術後癒着形成のリスクが高いこと、一般外科／腹部外科の手術件数が増加していること、一般外科／腹部外科向けに複数の接着バリア製品が商品化されていることなどの要因によるものと考えられる。

"アジア太平洋市場は予測期間中に最も高い成長を目撃する"
地域別に見ると、接着バリア市場は北米、欧州、アジア太平洋、中南米、中東、アフリカに区分される。接着バリア市場は、老年人口の着実な増加、感染症から慢性疾患への疫学的シフト、医療ツーリズムの増加などの要因により、APACでの成長が期待されている。その結果、APACは予測期間中に他の地域よりも急速に成長し、CAGRが最も高くなると予測されている。

本レポートで参照した接着バリア市場の主要参入企業（供給側）の内訳は以下の通りである：
a
- 企業タイプ別ティア1：42%、ティア2：35%、ティア3：23
- 役職別Cレベル：28%、取締役：35%、その他：2335%、その他37%
- 地域別北米：33%、ヨーロッパ：24%、アジア太平洋地域：18%、ラテンアメリカ：10%、中東：10%、アフリカ：5

接着バリア市場で事業を展開している主要企業は、バクスター・インターナショナル（米国）、ジョンソン・エンド・ジョンソン（J&J）（米国）、ベクトン・ディッキンソン・アンド・カンパニー（米国）、インテグラ・ライフサイエンシズ（米国）、アニカ・セラピューティクス（米国）、アトリウム・メディカル・コーポレーション（米国）、FzioMed（米国）、MASTバイオサージェリー（スイス）、Innocoll（アイルランド）、Betatech Medical（トルコ）、CorMatrix Cardiovascular, Inc.(米国）、テルモ株式会社（日本）、バイオコンパス社（米国）、W.L.ゴア＆アソシエイツ社（米国）、グンゼ株式会社（日本）、リーダーバイオメディカル社（オランダ）、Xlynk Surgical社（米国）、Luna Solutions社（米国）、PlantTec Medical GmbH社（ドイツ）、Actamax Surgical Materials, LLC社（米国）、Arc Medical Devices, INC.社（米国）、CG Bio INC.社（韓国）、生化学工業株式会社（日本）、Hangzhou Singclean Medical Products Co、Ltd.（中国）、Allosource（米国）。

調査対象範囲
この調査レポートは、様々なセグメントにわたる接着バリア市場を対象としています。製品別、製剤別、用途別、エンドユーザー別、地域別など、さまざまなセグメントにわたって市場規模と成長可能性を推定することを目的としています。また、主要企業の会社概要、製品・事業内容、最近の動向、主要市場戦略に関連する主な見解とともに、市場の主要企業の詳細な競合分析も掲載しています。

レポート購入の理由
本レポートは、粘着バリア市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供することで、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。


本レポートは、以下のポイントに関する洞察を提供します：
- 癒着バリア市場の成長に影響を与える主要促進要因（高齢者人口の増加、手術量とスポーツ関連傷害の増加、癒着の医学的意味合いに関する意識の高まり）、阻害要因（外科医の癒着バリア使用への消極性、製品リコール）、機会（未開拓の新興市場）、課題（厳しい規制による技術革新の制限）の分析
- 市場への浸透：世界の接着バリア市場のトップ企業が提供する製品ポートフォリオに関する包括的な情報。製品タイプ、剤形、用途、地域別に市場を分析。
- 製品の強化/革新：世界の接着バリア市場における今後の動向とサービス開始に関する詳細な洞察。
- 市場開発：製品タイプ、製剤、用途、地域別の有利な新興市場に関する包括的情報。
- 市場の多様化：世界の接着バリア市場における新製品とサービス、成長地域、最近の開発、投資に関する詳細な情報。
- 競合評価：世界の粘着バリア市場における主要企業の市場シェア、成長戦略、製品・サービス内容、能力を詳細に評価します。

ページTOPに戻る


目次

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 32
1.2.1 PRODUCT 32
1.2.2 FORMULATION 32
1.3 INCLUSIONS AND EXCLUSIONS 33
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 35
TABLE 1 STANDARD CURRENCY CONVERSION RATES 35
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 35
1.6.1 RECESSION IMPACT: ADHESION BARRIER MARKET 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 37
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY DATA 39
FIGURE 2 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 3 PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: BAXTER INTERNATIONAL 45
FIGURE 8 SUPPLY-SIDE ANALYSIS: ADHESION BARRIER MARKET 46
FIGURE 9 TOP-DOWN APPROACH 47
FIGURE 10 BOTTOM-UP APPROACH 47
FIGURE 11 US: ORTHOPEDIC SURGERIES APPROACH 48
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR ADHESION BARRIER MARKET (2023–2028) 49
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51
FIGURE 14 DATA TRIANGULATION METHODOLOGY 51
2.4 MARKET SHARE ESTIMATION 51
2.5 STUDY ASSUMPTIONS 52
2.6 RESEARCH LIMITATIONS 52
2.6.1 SCOPE-RELATED LIMITATIONS 52
2.6.2 METHODOLOGY-RELATED LIMITATIONS 53
2.7 RISK ASSESSMENT 53
TABLE 2 RISK ASSESSMENT: ADHESION BARRIER MARKET 53
2.8 IMPACT OF RECESSION ON ADHESION BARRIER MARKET 53
3 EXECUTIVE SUMMARY 54
FIGURE 15 ADHESION BARRIER MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 54
FIGURE 16 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2023 VS. 2028 (USD MILLION) 55
FIGURE 17 ADHESION BARRIER MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION) 55
FIGURE 18 ADHESION BARRIER MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 56
FIGURE 19 ADHESION BARRIER MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 57
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF ADHESION BARRIER MARKET 57
4 PREMIUM INSIGHTS 59
4.1 ADHESION BARRIER MARKET OVERVIEW 59
FIGURE 21 INCREASING VOLUME OF SURGERIES RISING GERIATRIC POPULATION TO DRIVE MARKET 59
4.2 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT AND COUNTRY (2022) 60
FIGURE 22 SYNTHETIC BARRIERS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ADHESION BARRIER MARKET IN 2022 60
4.3 ADHESION BARRIER MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 61
FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61
4.4 REGIONAL MIX: ADHESION BARRIER MARKET (2023−2028) 61
FIGURE 24 NORTH AMERICA TO DOMINATE ADHESION BARRIER MARKET IN 2028 61
4.5 ADHESION BARRIER MARKET: EMERGING VS. DEVELOPED ECONOMIES 62
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS: ADHESION BARRIER MARKET 63
5.2.1 DRIVERS 63
5.2.1.1 Rapid growth in geriatric population globally 63
TABLE 3 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020–2050 64
TABLE 4 LIST OF COMMON SPECIALTIES AND PROCEDURES IN OLDER ADULTS 64
5.2.1.2 Increase in volume of surgeries and sports-related injuries 65
TABLE 5 US: PERCENTAGE INCREASE IN NUMBER OF SURGICAL PROCEDURES PERFORMED (2010 VS. 2020) 65
5.2.1.3 Increasing awareness about medical implications of adhesions 65
5.2.2 RESTRAINTS 66
5.2.2.1 Reluctance of surgeons to use adhesion barriers 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Untapped markets in emerging economies 66
5.2.4 CHALLENGES 67
5.2.4.1 Stringent regulations and limited technological innovations 67
5.3 INDUSTRY TRENDS 67
5.3.1 RISING FOCUS ON GEL FORM OF ADHESION BARRIERS FOR SURGERIES 67
TABLE 6 AVERAGE ADHESION FORMATION RATE IN LAPAROSCOPIC SURGERIES 67
5.4 REGULATORY ANALYSIS 68
5.4.1 NORTH AMERICA 68
5.4.1.1 US 68
TABLE 7 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 68
FIGURE 26 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 69
5.4.1.2 Canada 69
FIGURE 27 APPROVAL PROCESS FOR CLASS III MEDICAL DEVICES IN CANADA 70
5.4.2 EUROPE 70
FIGURE 28 CE APPROVAL PROCESS IN EUROPE FOR BIOSURGERY PRODUCTS 70
5.4.3 ASIA PACIFIC 71
5.4.3.1 Japan 71
TABLE 8 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 71
5.4.3.2 China 71
TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION 72
5.4.3.3 India 72
5.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.6 VALUE CHAIN ANALYSIS 75
FIGURE 29 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING COMPONENT AND PRODUCT MANUFACTURING PHASE 76
5.7 SUPPLY CHAIN ANALYSIS 76
FIGURE 30 ADHESION BARRIER MARKET: SUPPLY CHAIN ANALYSIS 77
5.8 ECOSYSTEM MAPPING 78
FIGURE 31 ADHESION BARRIER MARKET: ECOSYSTEM MAPPING 78
5.9 PORTER'S FIVE FORCES ANALYSIS 79
TABLE 13 PORTER’S FIVE FORCES ANALYSIS 79
5.9.1 THREAT OF NEW ENTRANTS 79
5.9.2 THREAT OF SUBSTITUTES 80
5.9.3 BARGAINING POWER OF SUPPLIERS 80
5.9.4 BARGAINING POWER OF BUYERS 80
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.10 PATENT ANALYSIS 81
5.10.1 PATENT PUBLICATION TRENDS FOR ADHESION BARRIERS 81
FIGURE 32 ADHESION BARRIER MARKET: GLOBAL PATENT PUBLICATION TRENDS (2015–2023) 81
5.10.2 ADHESION BARRIER MARKET: TOP APPLICANTS 82
FIGURE 33 TOP APPLICANTS FOR ADHESION BARRIER PATENTS (2015–2023) 82
5.10.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS 82
FIGURE 34 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ADHESION BARRIER PATENTS (2015–2023) 82
5.11 TECHNOLOGY ANALYSIS 83
TABLE 14 ANTI-ADHESION BARRIERS AS SUBJECT OF RECENT RESEARCH 83
5.12 PRICING ANALYSIS 84
TABLE 15 AVERAGE SELLING PRICE OF ADHESION BARRIER PRODUCTS OFFERED BY KEY PLAYERS 84
5.13 KEY CONFERENCES AND EVENTS (2023–2025) 84
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 85
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 85
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ADHESION BARRIER PRODUCTS 85
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ADHESION BARRIER PRODUCTS 85
5.14.2 BUYING CRITERIA 86
FIGURE 36 KEY BUYING CRITERIA FOR ADHESION BARRIER PRODUCTS 86
TABLE 17 KEY BUYING CRITERIA FOR ADHESION BARRIER PRODUCTS 86
6 ADHESION BARRIER MARKET, BY PRODUCT 87
6.1 INTRODUCTION 88
TABLE 18 ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 88
6.2 SYNTHETIC ADHESION BARRIERS 88
TABLE 19 KEY BRANDS OF SYNTHETIC ADHESION BARRIERS 88
TABLE 20 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 21 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY COUNTRY, 2021–2028 (USD MILLION) 90
6.2.1 HYALURONIC ACID 90
6.2.1.1 Greater biocompatibility and higher bioresorbability to drive segment 90
TABLE 22 HYALURONIC ACID MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
6.2.2 REGENERATED CELLULOSE 91
6.2.2.1 Non-reactive and bacteriostatic nature of regenerated cellulose to drive use in gynecological surgeries 91
TABLE 23 REGENERATED CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.2.3 POLYETHYLENE GLYCOL 92
6.2.3.1 Ability to decrease post-surgical adhesions after abdominal and peritoneal surgeries to drive segment 92
TABLE 24 POLYETHYLENE GLYCOL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.2.4 OTHER SYNTHETIC ADHESION BARRIERS 93
TABLE 25 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.3 NATURAL ADHESION BARRIERS 94
6.3.1 TIME-CONSUMING AND COMPLEX APPLICATIONS DURING SURGERIES TO LIMIT MARKET 94
TABLE 26 LIST OF NATURAL ADHESION BARRIERS AVAILABLE 95
TABLE 27 ADHESION BARRIER MARKET FOR NATURAL ADHESION BARRIERS, BY COUNTRY, 2021–2028 (USD MILLION) 95
7 ADHESION BARRIER MARKET, BY FORMULATION 96
7.1 INTRODUCTION 97
TABLE 28 ADOPTION OF DIFFERENT ADHESION BARRIER FORMULATIONS IN SURGERIES 97
TABLE 29 ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 97
7.2 FILM FORMULATIONS 98
7.2.1 FILM FORMULATIONS DOMINATED ADHESION BARRIER MARKET IN 2022 98
TABLE 30 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH FILM FORMULATIONS 98
TABLE 31 ADHESION BARRIER MARKET FOR FILM FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
7.3 GEL FORMULATIONS 99
7.3.1 HIGHER PREFERENCE FOR GEL-BASED FORMULATIONS OVER FILM-BASED BARRIERS TO DRIVE MARKET 99
TABLE 32 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH GEL FORMULATIONS 100
TABLE 33 ADHESION BARRIER MARKET FOR GEL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 101
7.4 LIQUID FORMULATIONS 101
7.4.1 LIQUID FORMULATIONS TO BE WIDELY USED IN GYNECOLOGICAL, PELVIC, AND ABDOMINAL SURGERIES 101
TABLE 34 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH LIQUID FORMULATIONS 102
TABLE 35 ADHESION BARRIER MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102
8 ADHESION BARRIER MARKET, BY APPLICATION 103
8.1 INTRODUCTION 104
TABLE 36 ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
8.2 GENERAL/ABDOMINAL SURGERIES 104
8.2.1 INCREASING FORMATION OF POST-OPERATIVE ADHESIONS AND RISING COMPLICATIONS AMONG PATIENTS TO DRIVE MARKET 104
TABLE 37 ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 105
8.3 GYNECOLOGICAL SURGERIES 105
8.3.1 RISING INCIDENCE OF PELVIC AND UTERINE CANCER AND INCREASING NUMBER OF C-SECTIONS TO DRIVE MARKET 105
TABLE 38 PREVALENCE OF INTRAUTERINE ADHESIONS ACROSS DIFFERENT GYNECOLOGICAL PROCEDURES (IN %) 106
TABLE 39 COUNTRIES WITH HIGHEST C-SECTION RATES (2022) 106
TABLE 40 ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.4 CARDIOVASCULAR SURGERIES 108
8.4.1 INCREASING NUMBER OF POST-OPERATIVE COMPLICATIONS TO DRIVE MARKET 108
TABLE 41 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS FOR CARDIOVASCULAR SURGICAL APPLICATIONS 108
TABLE 42 ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 109
8.5 ORTHOPEDIC SURGERIES 109
8.5.1 GROWING NUMBER OF SPORT-RELATED INJURIES TO DRIVE MARKET 109
TABLE 43 ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 110
8.6 NEUROLOGICAL SURGERIES 110
8.6.1 GROWING CONCERNS ABOUT PHYSICAL PAIN AND IMPAIRMENT AFTER NEUROLOGICAL SURGERIES TO DRIVE MARKET 110
TABLE 44 ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.7 RECONSTRUCTIVE SURGERIES 111
8.7.1 HIGHER INSURANCE COVERAGE FOR COSMETIC SURGERIES TO DRIVE MARKET 111
TABLE 45 ADHESION BARRIER MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 112
8.8 UROLOGICAL SURGERIES 112
8.8.1 GROWING INCIDENCE OF POST-OPERATIVE ADHESION FORMATION TO DRIVE MARKET 112
TABLE 46 ADHESION BARRIER MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 113
8.9 OTHER SURGERIES 113
TABLE 47 ADHESION BARRIER MARKET FOR OTHER SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 114
9 ADHESION BARRIER MARKET, BY END USER 115
9.1 INTRODUCTION 116
TABLE 48 ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.2 HOSPITALS AND CLINICS 116
9.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND RISING ADOPTION OF SAFETY MEASURES TO DRIVE MARKET 116
TABLE 49 ADHESION BARRIER MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 117
9.3 AMBULATORY SURGICAL CENTERS 117
9.3.1 INCREASING NUMBER OF OUTPATIENT VISITS AND FAVORABLE REIMBURSEMENT POLICIES TO DRIVE MARKET 117
TABLE 50 ADHESION BARRIER MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 118
9.4 OTHER END USERS 119
TABLE 51 ADHESION BARRIER MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 119
10 ADHESION BARRIER MARKET, BY REGION 120
10.1 INTRODUCTION 121
TABLE 52 ADHESION BARRIER MARKET, BY REGION, 2021–2028 (USD MILLION) 121
10.2 NORTH AMERICA 122
TABLE 53 US: ARTHROPLASTY PROCEDURAL VOLUME, BY YEAR (N = 1,787,914) 122
10.2.1 NORTH AMERICA: RECESSION IMPACT 122
TABLE 54 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY (USD BILLION) 122
FIGURE 37 NORTH AMERICA: ADHESION BARRIER MARKET SNAPSHOT 123
TABLE 55 NORTH AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 56 NORTH AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 57 NORTH AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 58 NORTH AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 124
TABLE 59 NORTH AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
TABLE 60 NORTH AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 125
10.2.2 US 125
10.2.2.1 US dominated North American adhesion barrier market in 2022 125
FIGURE 38 GERIATRIC POPULATION IN US (65 YEARS AND ABOVE IN MILLION) 126
TABLE 61 US: KEY MACROINDICATORS 127
TABLE 62 US: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 127
TABLE 63 US: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 64 US: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 128
TABLE 65 US: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
TABLE 66 US: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.2.3 CANADA 129
10.2.3.1 Increasing number of C-section surgeries to drive market 129
TABLE 67 CANADA: KEY MACROINDICATORS 129
TABLE 68 CANADA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 69 CANADA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 70 CANADA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 130
TABLE 71 CANADA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 72 CANADA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 131
10.3 EUROPE 132
TABLE 73 EUROPEAN COUNTRIES WITH HIGHEST C-SECTION RATE (2021) 132
10.3.1 EUROPE: RECESSION IMPACT 132
TABLE 74 EUROPE: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 75 EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 76 EUROPE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 77 EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 134
TABLE 78 EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 79 EUROPE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.3.2 GERMANY 135
10.3.2.1 Germany accounted for largest share of European adhesion barrier market in 2022 135
TABLE 80 GERMANY: KEY MACROINDICATORS 135
TABLE 81 GERMANY: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 135
TABLE 82 GERMANY: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 83 GERMANY: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 136
TABLE 84 GERMANY: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 85 GERMANY: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 137
10.3.3 FRANCE 137
10.3.3.1 Rising number of advanced orthopedic surgeries to drive market 137
TABLE 86 FRANCE: KEY MACROINDICATORS 138
TABLE 87 FRANCE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
TABLE 88 FRANCE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 89 FRANCE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 139
TABLE 90 FRANCE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 91 FRANCE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 139
10.3.4 UK 140
10.3.4.1 Rising number of cardiovascular, gynecological, and orthopedic surgeries to drive market 140
TABLE 92 UK: PERCENTAGE SHARE OF AGING POPULATION (2019–2036) 140
TABLE 93 UK: KEY MACROINDICATORS 141
TABLE 94 UK: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 141
TABLE 95 UK: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 96 UK: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 142
TABLE 97 UK: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 98 UK: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 142
10.3.5 ITALY 143
10.3.5.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market 143
TABLE 99 ITALY: KEY MACROINDICATORS 143
TABLE 100 ITALY: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 144
TABLE 101 ITALY: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 102 ITALY: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 144
TABLE 103 ITALY: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 104 ITALY: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 145
10.3.6 SPAIN 145
10.3.6.1 High cost of surgical procedures to limit market 145
TABLE 105 SPAIN: KEY MACROINDICATORS 146
TABLE 106 SPAIN: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 146
TABLE 107 SPAIN: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 108 SPAIN: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 147
TABLE 109 SPAIN: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 110 SPAIN: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.3.7 REST OF EUROPE 148
TABLE 111 REST OF EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 112 REST OF EUROPE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 113 REST OF EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 150
TABLE 114 REST OF EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 115 REST OF EUROPE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.4 ASIA PACIFIC 151
FIGURE 39 ASIA PACIFIC: ADHESION BARRIER MARKET SNAPSHOT 152
10.4.1 ASIA PACIFIC: RECESSION IMPACT 152
TABLE 116 ASIA PACIFIC: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 117 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 118 ASIA PACIFIC: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 119 ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 154
TABLE 120 ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 121 ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.4.2 JAPAN 155
10.4.2.1 Rising geriatric population and increasing number of surgical procedures performed to drive market 155
TABLE 122 JAPAN: KEY MACROINDICATORS 156
TABLE 123 JAPAN: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 156
TABLE 124 JAPAN: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 125 JAPAN: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 157
TABLE 126 JAPAN: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 127 JAPAN: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 157
10.4.3 CHINA 158
10.4.3.1 Rapid economic growth and increasing disposable income of middle-class population to drive market 158
TABLE 128 CHINA: KEY MACROINDICATORS 158
TABLE 129 CHINA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 130 CHINA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 131 CHINA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 159
TABLE 132 CHINA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 160
TABLE 133 CHINA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.4.4 INDIA 160
10.4.4.1 Rising focus of multinational companies and improving urban healthcare infrastructure to drive market 160
TABLE 134 INDIA: KEY MACROINDICATORS 161
TABLE 135 INDIA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 161
TABLE 136 INDIA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 137 INDIA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 162
TABLE 138 INDIA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 139 INDIA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 163
10.4.5 AUSTRALIA 163
10.4.5.1 Growing government awareness campaigns and rising funding and grants for medical research to drive market 163
TABLE 140 AUSTRALIA: KEY MACROINDICATORS 164
TABLE 141 AUSTRALIA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 142 AUSTRALIA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 143 AUSTRALIA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 165
TABLE 144 AUSTRALIA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 145 AUSTRALIA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 165
10.4.6 SOUTH KOREA 166
10.4.6.1 Growing geriatric population and increasing disposable incomes to drive market 166
TABLE 146 SOUTH KOREA: KEY MACROINDICATORS 166
TABLE 147 SOUTH KOREA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 148 SOUTH KOREA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 149 SOUTH KOREA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 167
TABLE 150 SOUTH KOREA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 151 SOUTH KOREA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 168
10.4.7 REST OF ASIA PACIFIC 168
TABLE 152 NEW ZEALAND: REGISTERED JOINT ARTHROPLASTIES CONDUCTED FROM 2015–2021 169
TABLE 153 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 169
TABLE 154 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 155 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 170
TABLE 156 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 157 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 171
10.5 LATIN AMERICA 171
10.5.1 LATIN AMERICA: RECESSION IMPACT 171
TABLE 158 LATIN AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 159 LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 172
TABLE 160 LATIN AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 161 LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 173
TABLE 162 LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 163 LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 174
10.5.2 BRAZIL 174
10.5.2.1 Brazil to command largest market share for adhesion barriers in Latin America 174
TABLE 164 BRAZIL: KEY MACROINDICATORS 174
TABLE 165 BRAZIL: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 175
TABLE 166 BRAZIL: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 167 BRAZIL: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 175
TABLE 168 BRAZIL: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 169 BRAZIL: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.5.3 MEXICO 176
10.5.3.1 Rising burden of chronic diseases and well-organized healthcare system to drive market 176
TABLE 170 MEXICO: KEY MACROINDICATORS 177
TABLE 171 MEXICO: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 177
TABLE 172 MEXICO: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 173 MEXICO: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 178
TABLE 174 MEXICO: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 175 MEXICO: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 179
10.5.4 REST OF LATIN AMERICA 179
TABLE 176 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 180
TABLE 177 REST OF LATIN AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 178 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 180
TABLE 179 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181
TABLE 180 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 181
10.6 MIDDLE EAST & AFRICA 182
10.6.1 INCREASING NUMBER OF GYNECOLOGICAL AND GENERAL SURGERIES TO DRIVE MARKET 182
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 182
TABLE 181 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 183
TABLE 182 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 183 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 183
TABLE 184 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 184
TABLE 185 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 184
11 COMPETITIVE LANDSCAPE 185
11.1 OVERVIEW 185
11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN ADHESION BARRIER MARKET (JANUARY 2020– JULY 2023) 185
11.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 186
FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ADHESION BARRIER MARKET (2018–2022) 186
11.4 MARKET SHARE ANALYSIS 187
FIGURE 41 ADHESION BARRIER MARKET SHARE, BY KEY PLAYER, 2022 187
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 188
11.5.1 STARS 188
11.5.2 EMERGING LEADERS 189
11.5.3 PERVASIVE PLAYERS 189
11.5.4 PARTICIPANTS 189
FIGURE 42 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 190
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 191
11.6.1 PROGRESSIVE COMPANIES 191
11.6.2 DYNAMIC COMPANIES 191
11.6.3 STARTING BLOCKS 191
11.6.4 RESPONSIVE COMPANIES 191
FIGURE 43 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 192
11.7 COMPETITIVE BENCHMARKING 193
TABLE 186 PRODUCT PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 193
TABLE 187 FORMULATION PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 194
TABLE 188 APPLICATION PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 195
TABLE 189 END USER PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 196
TABLE 190 OVERALL PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 197
11.8 COMPANY GEOGRAPHICAL FOOTPRINT 198
TABLE 191 REGIONAL REVENUE MIX: ADHESION BARRIER MARKET 198
11.9 COMPETITIVE SITUATION AND TRENDS 199
11.9.1 KEY PRODUCT LAUNCHES AND APPROVALS 199
TABLE 192 KEY PRODUCT LAUNCHES AND APPROVALS 199
11.9.2 KEY ACQUISITIONS 200
12 COMPANY PROFILES 201
12.1 KEY PLAYERS 201
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 BAXTER INTERNATIONAL INC. 201
TABLE 193 BAXTER INTERNATIONAL INC: COMPANY OVERVIEW 201
FIGURE 44 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2022) 202
12.1.2 JOHNSON & JOHNSON 204
TABLE 194 JOHNSON & JOHNSON: COMPANY OVERVIEW 204
FIGURE 45 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 205
12.1.3 BECTON, DICKINSON AND COMPANY 207
TABLE 195 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 207
FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 208
12.1.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 210
TABLE 196 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW 210
FIGURE 47 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 211
12.1.5 ANIKA THERAPEUTICS INC. 213
TABLE 197 ANIKA THERAPEUTICS INC.: COMPANY OVERVIEW 213
FIGURE 48 ANIKA THERAPEUTICS INC.: COMPANY SNAPSHOT (2022) 214
12.1.6 ATRIUM MEDICAL CORPORATION 215
TABLE 198 ATRIUM MEDICAL CORPORATION: COMPANY OVERVIEW 215
FIGURE 49 ATRIUM MEDICAL CORPORATION: COMPANY SNAPSHOT (2022) 216
12.1.7 TERUMO CORPORATION 217
TABLE 199 TERUMO CORPORATION: COMPANY OVERVIEW 217
FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 218
12.1.8 FZIOMED, INC. 219
TABLE 200 FZIOMED, INC.: COMPANY OVERVIEW 219
12.1.9 MAST BIOSURGERY 220
TABLE 201 MAST BIOSURGERY: COMPANY OVERVIEW 220
12.1.10 INNOCOLL 221
TABLE 202 INNOCOLL: COMPANY OVERVIEW 221
12.1.11 BETATECH MEDICAL 222
TABLE 203 BETATECH MEDICAL: COMPANY OVERVIEW 222
12.1.12 CORMATRIX CARDIOVASCULAR, INC. 223
TABLE 204 CORMATRIX CARDIOVASCULAR, INC.: COMPANY OVERVIEW 223
12.1.13 BIOSCOMPASS, INC. 224
TABLE 205 BIOSCOMPASS, INC.: COMPANY OVERVIEW 224
12.1.14 W.L. GORE & ASSOCIATES, INC. 225
TABLE 206 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 225
12.1.15 ALLOSOURCE 226
TABLE 207 ALLOSOURCE: COMPANY OVERVIEW 226
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS (ADHESION BARRIER PRODUCTS UNDER DEVELOPMENT) 227
12.2.1 XLYNK SURGICAL 227
12.2.2 LUNA INNOVATIONS 227
12.2.3 ACTAMAX SURGICAL MATERIAL, LLC 227
12.2.4 ARC MEDICAL INC. 228
12.2.5 CG BIO INC. 228
12.2.6 LEADER BIOMEDICAL 228
12.2.7 PLANTTEC MEDICAL GMBH 228
12.2.8 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD. 229
12.2.9 SEIKAGAKU CORPORATION 229
12.2.10 GUNZE LIMITED 229
13 APPENDIX 230
13.1 DISCUSSION GUIDE 230
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
13.3 CUSTOMIZATION OPTIONS 237
13.4 RELATED REPORTS 237
13.5 AUTHOR DETAILS 238

　

ページTOPに戻る


　

Summary

The adhesion barriers market is valued at an estimated USD 0.7 billion in 2023 and is projected to reach USD 0.9 baillion by 2028, at a CAGR of 7.4% during the forecast period. The main drivers promoting the development of this market are the rising number of surgeries and sports-related injuries, an increasing elderly population, and the rising awareness of adhesion formation and diseases associated with adhesions.

“The synthetic adhesion barrier market is projected to witness the highest growth in the adhesion barriers market, by type of products, during the forecast period.”
Based on products, the adhesion barriers market is further segmented into synthetic and natural adhesion barriers. Synthetic adhesion barriers are further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol, and other synthetic adhesion barriers. the hyaluronic acid based adhesion barriers segment accounted for the largest share of the synthetic adhesion barrier market, owing to their properties of biocompatibility and bioresorbable.

“General/Abdominal Surgeries is the largest application segment of the adhesion barrier market.”
In 2022, based on applications, General/Abdominal Surgeries held the largest share of the adhesion barriers market. The large share of this segment can be attributed to factors such as the higher risk of post-surgical adhesion formation in General/Abdominal Surgeries, the growing volume of General/Abdominal Surgeries, and the availability of several commercialized adhesion barrier products for General/Abdominal Surgeries.

“Asia Pacific market to witness the highest growth during the forecast period”
On the basis of region, the adhesion barriers market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Adhesion barrier market is expected to grow in the APAC due to factors such as steadily increasing geriatric population, the epidemiological shift from infectious to chronic diseases, and rising medical tourism. As a result, the APAC is anticipated to grow faster than other regions during the forecast period with the highest CAGR.

A breakdown of the primary participants (supply-side) for the adhesion barrier market referred to for this report is provided below:
a
• By Company Type: Tier 1: 42%, Tier 2: 35%, and Tier 3: 23%
• By Designation: C-level Executives: 28%, Directors: 35%, and Others: 37%
• By Region: North America: 33%, Europe: 24%, Asia Pacific: 18%, Latin America: 10%; Middle East: 10%; Africa: 5%

The prominent players operating in the adhesion barriers market are Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), GUNZE Limited (Japan), Leader Biomedical (Netherlands), Xlynk Surgical (US), Luna Solutions (US), PlantTec Medical GmbH (Germany), Actamax Surgical Materials, LLC (US), Arc Medical Devices, INC. (US), CG Bio INC. (Korea), Seikagaku Corporation (Japan), Hangzhou Singclean Medical Products Co.,Ltd (China)and Allosource (US).

Research Coverage:
The market study covers the adhesion barrier market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by formulation, by application, by end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall adhesion barrier market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.


This report provides insights into the following pointers:
• Analysis of key drivers (Rising geriatric population, Increase in the volume of surgeries and sports-related injuries, Increasing awareness about the medical implications of adhesions), restraints (Reluctance of surgeons to use adhesion barriers, Product recalls), opportunities (Untapped emerging markets) and challenges (Stringent regulations resulting in limited technological innovations) influencing the growth of the adhesion barrier market
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global adhesion barrier market. The report analyzes this market by type of product , formulation, application, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global adhesion barrier market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product , formulation, application, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global adhesion barrier market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global adhesion barrier market.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 32
1.2.1 PRODUCT 32
1.2.2 FORMULATION 32
1.3 INCLUSIONS AND EXCLUSIONS 33
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 35
TABLE 1 STANDARD CURRENCY CONVERSION RATES 35
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 35
1.6.1 RECESSION IMPACT: ADHESION BARRIER MARKET 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 37
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY DATA 39
FIGURE 2 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 3 PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: BAXTER INTERNATIONAL 45
FIGURE 8 SUPPLY-SIDE ANALYSIS: ADHESION BARRIER MARKET 46
FIGURE 9 TOP-DOWN APPROACH 47
FIGURE 10 BOTTOM-UP APPROACH 47
FIGURE 11 US: ORTHOPEDIC SURGERIES APPROACH 48
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR ADHESION BARRIER MARKET (2023–2028) 49
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51
FIGURE 14 DATA TRIANGULATION METHODOLOGY 51
2.4 MARKET SHARE ESTIMATION 51
2.5 STUDY ASSUMPTIONS 52
2.6 RESEARCH LIMITATIONS 52
2.6.1 SCOPE-RELATED LIMITATIONS 52
2.6.2 METHODOLOGY-RELATED LIMITATIONS 53
2.7 RISK ASSESSMENT 53
TABLE 2 RISK ASSESSMENT: ADHESION BARRIER MARKET 53
2.8 IMPACT OF RECESSION ON ADHESION BARRIER MARKET 53
3 EXECUTIVE SUMMARY 54
FIGURE 15 ADHESION BARRIER MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 54
FIGURE 16 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2023 VS. 2028 (USD MILLION) 55
FIGURE 17 ADHESION BARRIER MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION) 55
FIGURE 18 ADHESION BARRIER MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 56
FIGURE 19 ADHESION BARRIER MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 57
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF ADHESION BARRIER MARKET 57
4 PREMIUM INSIGHTS 59
4.1 ADHESION BARRIER MARKET OVERVIEW 59
FIGURE 21 INCREASING VOLUME OF SURGERIES RISING GERIATRIC POPULATION TO DRIVE MARKET 59
4.2 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT AND COUNTRY (2022) 60
FIGURE 22 SYNTHETIC BARRIERS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ADHESION BARRIER MARKET IN 2022 60
4.3 ADHESION BARRIER MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 61
FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61
4.4 REGIONAL MIX: ADHESION BARRIER MARKET (2023−2028) 61
FIGURE 24 NORTH AMERICA TO DOMINATE ADHESION BARRIER MARKET IN 2028 61
4.5 ADHESION BARRIER MARKET: EMERGING VS. DEVELOPED ECONOMIES 62
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS: ADHESION BARRIER MARKET 63
5.2.1 DRIVERS 63
5.2.1.1 Rapid growth in geriatric population globally 63
TABLE 3 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020–2050 64
TABLE 4 LIST OF COMMON SPECIALTIES AND PROCEDURES IN OLDER ADULTS 64
5.2.1.2 Increase in volume of surgeries and sports-related injuries 65
TABLE 5 US: PERCENTAGE INCREASE IN NUMBER OF SURGICAL PROCEDURES PERFORMED (2010 VS. 2020) 65
5.2.1.3 Increasing awareness about medical implications of adhesions 65
5.2.2 RESTRAINTS 66
5.2.2.1 Reluctance of surgeons to use adhesion barriers 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Untapped markets in emerging economies 66
5.2.4 CHALLENGES 67
5.2.4.1 Stringent regulations and limited technological innovations 67
5.3 INDUSTRY TRENDS 67
5.3.1 RISING FOCUS ON GEL FORM OF ADHESION BARRIERS FOR SURGERIES 67
TABLE 6 AVERAGE ADHESION FORMATION RATE IN LAPAROSCOPIC SURGERIES 67
5.4 REGULATORY ANALYSIS 68
5.4.1 NORTH AMERICA 68
5.4.1.1 US 68
TABLE 7 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 68
FIGURE 26 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 69
5.4.1.2 Canada 69
FIGURE 27 APPROVAL PROCESS FOR CLASS III MEDICAL DEVICES IN CANADA 70
5.4.2 EUROPE 70
FIGURE 28 CE APPROVAL PROCESS IN EUROPE FOR BIOSURGERY PRODUCTS 70
5.4.3 ASIA PACIFIC 71
5.4.3.1 Japan 71
TABLE 8 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 71
5.4.3.2 China 71
TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION 72
5.4.3.3 India 72
5.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.6 VALUE CHAIN ANALYSIS 75
FIGURE 29 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING COMPONENT AND PRODUCT MANUFACTURING PHASE 76
5.7 SUPPLY CHAIN ANALYSIS 76
FIGURE 30 ADHESION BARRIER MARKET: SUPPLY CHAIN ANALYSIS 77
5.8 ECOSYSTEM MAPPING 78
FIGURE 31 ADHESION BARRIER MARKET: ECOSYSTEM MAPPING 78
5.9 PORTER'S FIVE FORCES ANALYSIS 79
TABLE 13 PORTER’S FIVE FORCES ANALYSIS 79
5.9.1 THREAT OF NEW ENTRANTS 79
5.9.2 THREAT OF SUBSTITUTES 80
5.9.3 BARGAINING POWER OF SUPPLIERS 80
5.9.4 BARGAINING POWER OF BUYERS 80
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.10 PATENT ANALYSIS 81
5.10.1 PATENT PUBLICATION TRENDS FOR ADHESION BARRIERS 81
FIGURE 32 ADHESION BARRIER MARKET: GLOBAL PATENT PUBLICATION TRENDS (2015–2023) 81
5.10.2 ADHESION BARRIER MARKET: TOP APPLICANTS 82
FIGURE 33 TOP APPLICANTS FOR ADHESION BARRIER PATENTS (2015–2023) 82
5.10.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS 82
FIGURE 34 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ADHESION BARRIER PATENTS (2015–2023) 82
5.11 TECHNOLOGY ANALYSIS 83
TABLE 14 ANTI-ADHESION BARRIERS AS SUBJECT OF RECENT RESEARCH 83
5.12 PRICING ANALYSIS 84
TABLE 15 AVERAGE SELLING PRICE OF ADHESION BARRIER PRODUCTS OFFERED BY KEY PLAYERS 84
5.13 KEY CONFERENCES AND EVENTS (2023–2025) 84
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 85
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 85
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ADHESION BARRIER PRODUCTS 85
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ADHESION BARRIER PRODUCTS 85
5.14.2 BUYING CRITERIA 86
FIGURE 36 KEY BUYING CRITERIA FOR ADHESION BARRIER PRODUCTS 86
TABLE 17 KEY BUYING CRITERIA FOR ADHESION BARRIER PRODUCTS 86
6 ADHESION BARRIER MARKET, BY PRODUCT 87
6.1 INTRODUCTION 88
TABLE 18 ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 88
6.2 SYNTHETIC ADHESION BARRIERS 88
TABLE 19 KEY BRANDS OF SYNTHETIC ADHESION BARRIERS 88
TABLE 20 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 21 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY COUNTRY, 2021–2028 (USD MILLION) 90
6.2.1 HYALURONIC ACID 90
6.2.1.1 Greater biocompatibility and higher bioresorbability to drive segment 90
TABLE 22 HYALURONIC ACID MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
6.2.2 REGENERATED CELLULOSE 91
6.2.2.1 Non-reactive and bacteriostatic nature of regenerated cellulose to drive use in gynecological surgeries 91
TABLE 23 REGENERATED CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.2.3 POLYETHYLENE GLYCOL 92
6.2.3.1 Ability to decrease post-surgical adhesions after abdominal and peritoneal surgeries to drive segment 92
TABLE 24 POLYETHYLENE GLYCOL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.2.4 OTHER SYNTHETIC ADHESION BARRIERS 93
TABLE 25 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.3 NATURAL ADHESION BARRIERS 94
6.3.1 TIME-CONSUMING AND COMPLEX APPLICATIONS DURING SURGERIES TO LIMIT MARKET 94
TABLE 26 LIST OF NATURAL ADHESION BARRIERS AVAILABLE 95
TABLE 27 ADHESION BARRIER MARKET FOR NATURAL ADHESION BARRIERS, BY COUNTRY, 2021–2028 (USD MILLION) 95
7 ADHESION BARRIER MARKET, BY FORMULATION 96
7.1 INTRODUCTION 97
TABLE 28 ADOPTION OF DIFFERENT ADHESION BARRIER FORMULATIONS IN SURGERIES 97
TABLE 29 ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 97
7.2 FILM FORMULATIONS 98
7.2.1 FILM FORMULATIONS DOMINATED ADHESION BARRIER MARKET IN 2022 98
TABLE 30 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH FILM FORMULATIONS 98
TABLE 31 ADHESION BARRIER MARKET FOR FILM FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
7.3 GEL FORMULATIONS 99
7.3.1 HIGHER PREFERENCE FOR GEL-BASED FORMULATIONS OVER FILM-BASED BARRIERS TO DRIVE MARKET 99
TABLE 32 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH GEL FORMULATIONS 100
TABLE 33 ADHESION BARRIER MARKET FOR GEL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 101
7.4 LIQUID FORMULATIONS 101
7.4.1 LIQUID FORMULATIONS TO BE WIDELY USED IN GYNECOLOGICAL, PELVIC, AND ABDOMINAL SURGERIES 101
TABLE 34 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH LIQUID FORMULATIONS 102
TABLE 35 ADHESION BARRIER MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102
8 ADHESION BARRIER MARKET, BY APPLICATION 103
8.1 INTRODUCTION 104
TABLE 36 ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
8.2 GENERAL/ABDOMINAL SURGERIES 104
8.2.1 INCREASING FORMATION OF POST-OPERATIVE ADHESIONS AND RISING COMPLICATIONS AMONG PATIENTS TO DRIVE MARKET 104
TABLE 37 ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 105
8.3 GYNECOLOGICAL SURGERIES 105
8.3.1 RISING INCIDENCE OF PELVIC AND UTERINE CANCER AND INCREASING NUMBER OF C-SECTIONS TO DRIVE MARKET 105
TABLE 38 PREVALENCE OF INTRAUTERINE ADHESIONS ACROSS DIFFERENT GYNECOLOGICAL PROCEDURES (IN %) 106
TABLE 39 COUNTRIES WITH HIGHEST C-SECTION RATES (2022) 106
TABLE 40 ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.4 CARDIOVASCULAR SURGERIES 108
8.4.1 INCREASING NUMBER OF POST-OPERATIVE COMPLICATIONS TO DRIVE MARKET 108
TABLE 41 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS FOR CARDIOVASCULAR SURGICAL APPLICATIONS 108
TABLE 42 ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 109
8.5 ORTHOPEDIC SURGERIES 109
8.5.1 GROWING NUMBER OF SPORT-RELATED INJURIES TO DRIVE MARKET 109
TABLE 43 ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 110
8.6 NEUROLOGICAL SURGERIES 110
8.6.1 GROWING CONCERNS ABOUT PHYSICAL PAIN AND IMPAIRMENT AFTER NEUROLOGICAL SURGERIES TO DRIVE MARKET 110
TABLE 44 ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.7 RECONSTRUCTIVE SURGERIES 111
8.7.1 HIGHER INSURANCE COVERAGE FOR COSMETIC SURGERIES TO DRIVE MARKET 111
TABLE 45 ADHESION BARRIER MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 112
8.8 UROLOGICAL SURGERIES 112
8.8.1 GROWING INCIDENCE OF POST-OPERATIVE ADHESION FORMATION TO DRIVE MARKET 112
TABLE 46 ADHESION BARRIER MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 113
8.9 OTHER SURGERIES 113
TABLE 47 ADHESION BARRIER MARKET FOR OTHER SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 114
9 ADHESION BARRIER MARKET, BY END USER 115
9.1 INTRODUCTION 116
TABLE 48 ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.2 HOSPITALS AND CLINICS 116
9.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND RISING ADOPTION OF SAFETY MEASURES TO DRIVE MARKET 116
TABLE 49 ADHESION BARRIER MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 117
9.3 AMBULATORY SURGICAL CENTERS 117
9.3.1 INCREASING NUMBER OF OUTPATIENT VISITS AND FAVORABLE REIMBURSEMENT POLICIES TO DRIVE MARKET 117
TABLE 50 ADHESION BARRIER MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 118
9.4 OTHER END USERS 119
TABLE 51 ADHESION BARRIER MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 119
10 ADHESION BARRIER MARKET, BY REGION 120
10.1 INTRODUCTION 121
TABLE 52 ADHESION BARRIER MARKET, BY REGION, 2021–2028 (USD MILLION) 121
10.2 NORTH AMERICA 122
TABLE 53 US: ARTHROPLASTY PROCEDURAL VOLUME, BY YEAR (N = 1,787,914) 122
10.2.1 NORTH AMERICA: RECESSION IMPACT 122
TABLE 54 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY (USD BILLION) 122
FIGURE 37 NORTH AMERICA: ADHESION BARRIER MARKET SNAPSHOT 123
TABLE 55 NORTH AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 56 NORTH AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 57 NORTH AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 58 NORTH AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 124
TABLE 59 NORTH AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
TABLE 60 NORTH AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 125
10.2.2 US 125
10.2.2.1 US dominated North American adhesion barrier market in 2022 125
FIGURE 38 GERIATRIC POPULATION IN US (65 YEARS AND ABOVE IN MILLION) 126
TABLE 61 US: KEY MACROINDICATORS 127
TABLE 62 US: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 127
TABLE 63 US: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 64 US: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 128
TABLE 65 US: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
TABLE 66 US: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.2.3 CANADA 129
10.2.3.1 Increasing number of C-section surgeries to drive market 129
TABLE 67 CANADA: KEY MACROINDICATORS 129
TABLE 68 CANADA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 69 CANADA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 70 CANADA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 130
TABLE 71 CANADA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 72 CANADA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 131
10.3 EUROPE 132
TABLE 73 EUROPEAN COUNTRIES WITH HIGHEST C-SECTION RATE (2021) 132
10.3.1 EUROPE: RECESSION IMPACT 132
TABLE 74 EUROPE: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 75 EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 76 EUROPE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 77 EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 134
TABLE 78 EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 79 EUROPE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.3.2 GERMANY 135
10.3.2.1 Germany accounted for largest share of European adhesion barrier market in 2022 135
TABLE 80 GERMANY: KEY MACROINDICATORS 135
TABLE 81 GERMANY: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 135
TABLE 82 GERMANY: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 83 GERMANY: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 136
TABLE 84 GERMANY: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 85 GERMANY: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 137
10.3.3 FRANCE 137
10.3.3.1 Rising number of advanced orthopedic surgeries to drive market 137
TABLE 86 FRANCE: KEY MACROINDICATORS 138
TABLE 87 FRANCE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
TABLE 88 FRANCE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 89 FRANCE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 139
TABLE 90 FRANCE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 91 FRANCE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 139
10.3.4 UK 140
10.3.4.1 Rising number of cardiovascular, gynecological, and orthopedic surgeries to drive market 140
TABLE 92 UK: PERCENTAGE SHARE OF AGING POPULATION (2019–2036) 140
TABLE 93 UK: KEY MACROINDICATORS 141
TABLE 94 UK: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 141
TABLE 95 UK: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 96 UK: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 142
TABLE 97 UK: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 98 UK: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 142
10.3.5 ITALY 143
10.3.5.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market 143
TABLE 99 ITALY: KEY MACROINDICATORS 143
TABLE 100 ITALY: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 144
TABLE 101 ITALY: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 102 ITALY: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 144
TABLE 103 ITALY: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 104 ITALY: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 145
10.3.6 SPAIN 145
10.3.6.1 High cost of surgical procedures to limit market 145
TABLE 105 SPAIN: KEY MACROINDICATORS 146
TABLE 106 SPAIN: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 146
TABLE 107 SPAIN: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 108 SPAIN: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 147
TABLE 109 SPAIN: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 110 SPAIN: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.3.7 REST OF EUROPE 148
TABLE 111 REST OF EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 112 REST OF EUROPE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 113 REST OF EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 150
TABLE 114 REST OF EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 115 REST OF EUROPE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.4 ASIA PACIFIC 151
FIGURE 39 ASIA PACIFIC: ADHESION BARRIER MARKET SNAPSHOT 152
10.4.1 ASIA PACIFIC: RECESSION IMPACT 152
TABLE 116 ASIA PACIFIC: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 117 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 118 ASIA PACIFIC: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 119 ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 154
TABLE 120 ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 121 ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.4.2 JAPAN 155
10.4.2.1 Rising geriatric population and increasing number of surgical procedures performed to drive market 155
TABLE 122 JAPAN: KEY MACROINDICATORS 156
TABLE 123 JAPAN: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 156
TABLE 124 JAPAN: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 125 JAPAN: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 157
TABLE 126 JAPAN: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 127 JAPAN: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 157
10.4.3 CHINA 158
10.4.3.1 Rapid economic growth and increasing disposable income of middle-class population to drive market 158
TABLE 128 CHINA: KEY MACROINDICATORS 158
TABLE 129 CHINA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 130 CHINA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 131 CHINA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 159
TABLE 132 CHINA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 160
TABLE 133 CHINA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.4.4 INDIA 160
10.4.4.1 Rising focus of multinational companies and improving urban healthcare infrastructure to drive market 160
TABLE 134 INDIA: KEY MACROINDICATORS 161
TABLE 135 INDIA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 161
TABLE 136 INDIA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 137 INDIA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 162
TABLE 138 INDIA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 139 INDIA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 163
10.4.5 AUSTRALIA 163
10.4.5.1 Growing government awareness campaigns and rising funding and grants for medical research to drive market 163
TABLE 140 AUSTRALIA: KEY MACROINDICATORS 164
TABLE 141 AUSTRALIA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 142 AUSTRALIA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 143 AUSTRALIA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 165
TABLE 144 AUSTRALIA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 145 AUSTRALIA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 165
10.4.6 SOUTH KOREA 166
10.4.6.1 Growing geriatric population and increasing disposable incomes to drive market 166
TABLE 146 SOUTH KOREA: KEY MACROINDICATORS 166
TABLE 147 SOUTH KOREA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 148 SOUTH KOREA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 149 SOUTH KOREA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 167
TABLE 150 SOUTH KOREA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 151 SOUTH KOREA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 168
10.4.7 REST OF ASIA PACIFIC 168
TABLE 152 NEW ZEALAND: REGISTERED JOINT ARTHROPLASTIES CONDUCTED FROM 2015–2021 169
TABLE 153 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 169
TABLE 154 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 155 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 170
TABLE 156 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 157 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 171
10.5 LATIN AMERICA 171
10.5.1 LATIN AMERICA: RECESSION IMPACT 171
TABLE 158 LATIN AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 159 LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 172
TABLE 160 LATIN AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 161 LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 173
TABLE 162 LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 163 LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 174
10.5.2 BRAZIL 174
10.5.2.1 Brazil to command largest market share for adhesion barriers in Latin America 174
TABLE 164 BRAZIL: KEY MACROINDICATORS 174
TABLE 165 BRAZIL: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 175
TABLE 166 BRAZIL: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 167 BRAZIL: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 175
TABLE 168 BRAZIL: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 169 BRAZIL: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.5.3 MEXICO 176
10.5.3.1 Rising burden of chronic diseases and well-organized healthcare system to drive market 176
TABLE 170 MEXICO: KEY MACROINDICATORS 177
TABLE 171 MEXICO: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 177
TABLE 172 MEXICO: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 173 MEXICO: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 178
TABLE 174 MEXICO: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 175 MEXICO: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 179
10.5.4 REST OF LATIN AMERICA 179
TABLE 176 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 180
TABLE 177 REST OF LATIN AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 178 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 180
TABLE 179 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181
TABLE 180 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 181
10.6 MIDDLE EAST & AFRICA 182
10.6.1 INCREASING NUMBER OF GYNECOLOGICAL AND GENERAL SURGERIES TO DRIVE MARKET 182
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 182
TABLE 181 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 183
TABLE 182 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 183 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 183
TABLE 184 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 184
TABLE 185 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 184
11 COMPETITIVE LANDSCAPE 185
11.1 OVERVIEW 185
11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN ADHESION BARRIER MARKET (JANUARY 2020– JULY 2023) 185
11.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 186
FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ADHESION BARRIER MARKET (2018–2022) 186
11.4 MARKET SHARE ANALYSIS 187
FIGURE 41 ADHESION BARRIER MARKET SHARE, BY KEY PLAYER, 2022 187
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 188
11.5.1 STARS 188
11.5.2 EMERGING LEADERS 189
11.5.3 PERVASIVE PLAYERS 189
11.5.4 PARTICIPANTS 189
FIGURE 42 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 190
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 191
11.6.1 PROGRESSIVE COMPANIES 191
11.6.2 DYNAMIC COMPANIES 191
11.6.3 STARTING BLOCKS 191
11.6.4 RESPONSIVE COMPANIES 191
FIGURE 43 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 192
11.7 COMPETITIVE BENCHMARKING 193
TABLE 186 PRODUCT PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 193
TABLE 187 FORMULATION PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 194
TABLE 188 APPLICATION PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 195
TABLE 189 END USER PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 196
TABLE 190 OVERALL PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 197
11.8 COMPANY GEOGRAPHICAL FOOTPRINT 198
TABLE 191 REGIONAL REVENUE MIX: ADHESION BARRIER MARKET 198
11.9 COMPETITIVE SITUATION AND TRENDS 199
11.9.1 KEY PRODUCT LAUNCHES AND APPROVALS 199
TABLE 192 KEY PRODUCT LAUNCHES AND APPROVALS 199
11.9.2 KEY ACQUISITIONS 200
12 COMPANY PROFILES 201
12.1 KEY PLAYERS 201
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 BAXTER INTERNATIONAL INC. 201
TABLE 193 BAXTER INTERNATIONAL INC: COMPANY OVERVIEW 201
FIGURE 44 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2022) 202
12.1.2 JOHNSON & JOHNSON 204
TABLE 194 JOHNSON & JOHNSON: COMPANY OVERVIEW 204
FIGURE 45 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 205
12.1.3 BECTON, DICKINSON AND COMPANY 207
TABLE 195 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 207
FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 208
12.1.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 210
TABLE 196 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW 210
FIGURE 47 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 211
12.1.5 ANIKA THERAPEUTICS INC. 213
TABLE 197 ANIKA THERAPEUTICS INC.: COMPANY OVERVIEW 213
FIGURE 48 ANIKA THERAPEUTICS INC.: COMPANY SNAPSHOT (2022) 214
12.1.6 ATRIUM MEDICAL CORPORATION 215
TABLE 198 ATRIUM MEDICAL CORPORATION: COMPANY OVERVIEW 215
FIGURE 49 ATRIUM MEDICAL CORPORATION: COMPANY SNAPSHOT (2022) 216
12.1.7 TERUMO CORPORATION 217
TABLE 199 TERUMO CORPORATION: COMPANY OVERVIEW 217
FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 218
12.1.8 FZIOMED, INC. 219
TABLE 200 FZIOMED, INC.: COMPANY OVERVIEW 219
12.1.9 MAST BIOSURGERY 220
TABLE 201 MAST BIOSURGERY: COMPANY OVERVIEW 220
12.1.10 INNOCOLL 221
TABLE 202 INNOCOLL: COMPANY OVERVIEW 221
12.1.11 BETATECH MEDICAL 222
TABLE 203 BETATECH MEDICAL: COMPANY OVERVIEW 222
12.1.12 CORMATRIX CARDIOVASCULAR, INC. 223
TABLE 204 CORMATRIX CARDIOVASCULAR, INC.: COMPANY OVERVIEW 223
12.1.13 BIOSCOMPASS, INC. 224
TABLE 205 BIOSCOMPASS, INC.: COMPANY OVERVIEW 224
12.1.14 W.L. GORE & ASSOCIATES, INC. 225
TABLE 206 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 225
12.1.15 ALLOSOURCE 226
TABLE 207 ALLOSOURCE: COMPANY OVERVIEW 226
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS (ADHESION BARRIER PRODUCTS UNDER DEVELOPMENT) 227
12.2.1 XLYNK SURGICAL 227
12.2.2 LUNA INNOVATIONS 227
12.2.3 ACTAMAX SURGICAL MATERIAL, LLC 227
12.2.4 ARC MEDICAL INC. 228
12.2.5 CG BIO INC. 228
12.2.6 LEADER BIOMEDICAL 228
12.2.7 PLANTTEC MEDICAL GMBH 228
12.2.8 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD. 229
12.2.9 SEIKAGAKU CORPORATION 229
12.2.10 GUNZE LIMITED 229
13 APPENDIX 230
13.1 DISCUSSION GUIDE 230
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
13.3 CUSTOMIZATION OPTIONS 237
13.4 RELATED REPORTS 237
13.5 AUTHOR DETAILS 238

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（abdominal）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/08　10:26

154.13 円

166.76 円

202.76 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.